Triptorelin
Decapeptyl, Trelstar, Gonapeptyl, Pamorelin
A synthetic GnRH agonist decapeptide that suppresses gonadotropin and sex hormone production for treating prostate cancer, endometriosis, and precocious puberty.
Unknown
NCT02673632
The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS
Ain Shams Maternity Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03397537
Neoadjuvant Endocrine Therapy in Breast Cancer
Guangdong Provincial People's Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NCT00635258
Administration of GnRH Antagonist to Oocyte Donation Recipients
Centro Ginecologia y Obstetricia.
OBSERVATIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT00194792
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
University of Washington
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE2
NCT06225284
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
National Taiwan University Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE4
NCT01673984
GP Extended Action Triptorelin
Ipsen
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT05352178
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Universitaire Ziekenhuizen KU Leuven
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2
NCT02972060
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT04064840
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
The University of Hong Kong
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT01565265
Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression
University Hospital, Basel, Switzerland
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT02199587
The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test
Meir Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2, PHASE3
NCT03353883
Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?
Benha University
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT05328258
Use of GnRHa During Chemotherapy for Fertility Protection
Kenny Rodriguez-Wallberg
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04224818
Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders
American University of Beirut Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT01897324
IVF/ICSI Protocols in Poor Responders With Growth Hormone
Woman's Health University Hospital, Egypt
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE1
NCT02908438
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT04181203
Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy
UNICANCER
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT01353846
Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients
Instituto Valenciano de Infertilidad, IVI VALENCIA
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NCT05801705
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OBSERVATIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT04513717
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
NRG Oncology
INTERVENTIONAL
Updated Dec 15, 2025